The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma

J. Schmid (Aarhus, Denmark), B. Hviid-Vyff (Aarhus, Denmark), T. Skjold (Aarhus, Denmark), H. Hoffmann (Aarhus, Denmark)

Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Session: Eosinophils and FeNO in airway diseases
Session type: Oral Presentation
Number: 2150
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Schmid (Aarhus, Denmark), B. Hviid-Vyff (Aarhus, Denmark), T. Skjold (Aarhus, Denmark), H. Hoffmann (Aarhus, Denmark). The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma. 2150

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
FENO and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010

Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD
Source: Eur Respir J 2016; 47:1562-1564
Year: 2016


Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO.
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020


Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA)
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020


Biological markers of inflammation in asthma in children - eosinophils in sputum and ECP in peripheral blood
Source: Eur Respir J 2005; 26: Suppl. 49, 625s
Year: 2005

Predictors of sputum eosinophilia in severe asthma
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020


A study on the relevance of eosinophil counts in induced sputum and FENO and lung functions in asthmatics
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010


Mepolizumab does not alter blood basophil count in severe asthma
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019

Role of blood neutrophilia as a biomarker in asthma
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018

Evaluation of FeNo measurement as an alternative to sputum eosinophils in a severe asthma population
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017

Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study
Source: Eur Respir J, 51 (5) 1702523; 10.1183/13993003.02523-2017
Year: 2018



Correlation between nasal secretion eosinophilia and induced sputum eosiniphilia in pediatric asthma
Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood
Year: 2010


Role of sputum eosinophil levels in the assessment of asthma treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 579s
Year: 2004

Stability of sputum and blood eosinophil levels in COPD
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020


The blood eosinophil count as a biomarker in COPD
Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD
Year: 2015



Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018

Sputum eosinophilia vs exhaled NO as markers of airways inflammation in asthma: relationship with asthma control
Source: Eur Respir J 2005; 26: Suppl. 49, 736s
Year: 2005

Airway eosinophilia is not related to clinical and functional findings in a large group of severe refractory asthmatics
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Year: 2006


High sputum ECP levels detect functional impairment in asthma better than sputum eosinophils
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010